Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 400 participants.
Also called NCT05496998
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT05496998
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark, France, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05496998. Allocation not applicable; no masking; primary purpose treatment. Start 2023-02-07 (actual); primary completion 2029-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
- Acronym
- APOLLO-EU
- Condition
- Mitral Regurgitation
- Intervention (Device)
- Medtronic Intrepid™ TMVR TF System
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct05496998- Content hash
531662b66cb2cbc9e83d0d89b47b9a937e5d5bda14feb053cccd90964d4fead1